跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DABIGATRAN ETEXILATO PENSA 150 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DABIGATRAN ETEXILATO PENSA 150 MG CAPSULAS DURAS EFG
Approved
STANDARD
DABIGATRAN ETEXILATO PENSA 150 MG CAPSULAS DURAS EFG
Towa Pharmaceutical S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 9, 2022
Approval ID
75dbfa9c485bf5e4
Company
Towa Pharmaceutical S.A.
Type
Standard
Approval Details
Approval Id
75dbfa9c485bf5e4
Drug Cima Aemps Name
DABIGATRAN ETEXILATO PENSA 150 MG CAPSULAS DURAS EFG
Register Number
88370
Holder Company Name
Towa Pharmaceutical S.A.
Marketing Company Name
Towa Pharmaceutical S.A.
Authorization Date
2022-12-09
Dosage Form
CÁPSULA DURA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Towa Pharmaceutical S.A.
Active Ingredients
DABIGATRAN ETEXILATO MESILATO
172,95 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 9, 2022
Approval ID
75dbfa9c485bf5e4
Type
Standard
Back to CIMA-AEMPS Approvals
